C07C 323/24
Having the sulfur atoms of the thio groups bound to acyclic carbon
Official title: having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
C07C323/24 (Having the sulfur atoms of the thio groups bound to acyclic carbon) appears on 722 US grants and 510 published applications in this corpus.
Search patents in C07C- Granted patents
- 722
- Published applications
- 510
- Assignees
- 390
- Inventors
- 1,718
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 6 | 0 |
| 1977 | 3 | 0 |
| 1978 | 6 | 0 |
| 1979 | 7 | 0 |
| 1980 | 14 | 0 |
| 1981 | 15 | 0 |
| 1982 | 8 | 0 |
| 1983 | 4 | 0 |
| 1984 | 5 | 0 |
| 1985 | 3 | 0 |
| 1986 | 8 | 0 |
| 1987 | 7 | 0 |
| 1988 | 9 | 0 |
| 1989 | 24 | 0 |
| 1990 | 19 | 0 |
| 1991 | 19 | 0 |
| 1992 | 20 | 0 |
| 1993 | 17 | 0 |
| 1994 | 14 | 0 |
| 1995 | 17 | 0 |
| 1996 | 22 | 0 |
| 1997 | 32 | 0 |
| 1998 | 23 | 0 |
| 1999 | 16 | 0 |
| 2000 | 10 | 0 |
| 2001 | 7 | 0 |
| 2002 | 25 | 26 |
| 2003 | 21 | 34 |
| 2004 | 23 | 26 |
| 2005 | 19 | 25 |
| 2006 | 7 | 19 |
| 2007 | 22 | 15 |
| 2008 | 12 | 15 |
| 2009 | 8 | 23 |
| 2010 | 11 | 13 |
| 2011 | 13 | 16 |
| 2012 | 13 | 19 |
| 2013 | 16 | 23 |
| 2014 | 21 | 21 |
| 2015 | 18 | 34 |
| 2016 | 24 | 15 |
| 2017 | 21 | 20 |
| 2018 | 13 | 30 |
| 2019 | 14 | 21 |
| 2020 | 18 | 17 |
| 2021 | 13 | 16 |
| 2022 | 12 | 21 |
| 2023 | 14 | 16 |
| 2024 | 11 | 17 |
| 2025 | 9 | 17 |
| 2026 | 9 | 11 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C07C 323/25The carbon skeleton being acyclic and saturated627
- C07C 323/29The carbon skeleton containing six-membered aromatic rings83
- C07C 323/27The carbon skeleton being acyclic and unsaturated27
- C07C 323/26The carbon skeleton being saturated and containing rings10
- C07C 323/28The carbon skeleton being unsaturated and containing rings other than six-membered aromatic3
Recent patents
- Cationic lipid having disulfide bond, lipid membrane structure including same, nucleic acid introduction agent and pharmaceutical composition containing any one of same, method for introducing nucleic acid into cell or target cell, and method for producing cellular pharmaceutical29 Sep 2026US 12,746,202 B2National University Corporation Chiba University
- Process for the preparation of cysteamine bitartrate and product so obtained29 Sep 2026US 12,747,204 B2Recordati Industria Chimica e Farmaceutica S.p.A.
- Sulfur-containing lipids29 Sep 2026US 12,747,205 B2The University of British Columbia
- Structurally modified opioids for prevention and treatment of diseases and conditions26 May 2026US 12,637,411 B2Mggm LLC
- EP2 antagonist19 May 2026US 12,630,510 B2Ono Pharmaceutical Co., Ltd.
- Method for quantitatively analyzing polysulfide in sample27 Aug 2026US 2026/0250239 A1Bio-Xcelerator, Inc.
- Novel lipids and compositions for the delivery of therapeutics13 Aug 2026US 2026/0232810 A1Arbutus Biopharma Corporation
- Compounds and compositions for intracellular delivery of nucleic acid-based therapeutics and methods thereof30 Jul 2026US 2026/0216070 A1NanoTech Pharma Inc.
- Platinum complexes, related compositions, and uses thereof in cyanide counter-measures30 Jul 2026US 2026/0216120 A1Beth Israel Deaconess Medical Center, Inc.
- Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives16 Jul 2026US 2026/0200844 A1OrsoBio, Inc.
Most cited
By later US patents
- Diagnostic media413US 4,647,447 ASchering Corporation · 1987
- Method of enhancing NMR imaging using chelated paramagnetic ions bound to biomolecules213US 5,021,236 ASchering Corporation · 1991
- Retroviral protease inhibiting compounds159US 5,142,056 AAbbott Laboratories · 1992
- Lipid containing formulations152US 8,642,076 B2Tekmira Pharmaceuticals Corporation · 2014
- Thiol-modified hyaluronan121US 6,884,788 B2Anika Therapeutics, Inc. · 2005